Research
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e1401 (Published 27 March 2012) Cite this as: BMJ 2012;344:e1401
Data supplement
Web Extra
Extra material supplied by the author: Supplementary tables 1 and 2 showing effects of using 60 day or 90 day interval between initial surgery or disease diagnosis and subsequent disease diagnoses on vaccine efficacy estimates
Files in this Data Supplement:
Related articles
- Editorial Published: 27 March 2012; BMJ 344 doi:10.1136/bmj.e1544
- Research Published: 04 March 2014; BMJ 348 doi:10.1136/bmj.g1458
- Letter Published: 08 May 2012; BMJ 344 doi:10.1136/bmj.e3195
- Research Published: 03 August 2022; BMJ 378 doi:10.1136/bmj-2022-070135
See more
- Breast cancer: Inaction on inequalities has led to unequal progress, say expertsBMJ April 16, 2024, 385 q854; DOI: https://doi.org/10.1136/bmj.q854
- Cancer: Fast tracked drugs often do not improve clinical outcomes, say researchersBMJ April 08, 2024, 385 q818; DOI: https://doi.org/10.1136/bmj.q818
- NHS rolls out fast tracked immunotherapy for advanced endometrial cancerBMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557
- Teledentistry may help in detecting oral cancers in current GP and dentist shortagesBMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512
- UK’s progress on cancer survival has slowed in past decade, figures showBMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290
Cited by...
- Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical excision: a meta-analysis and meta-regression
- Human papillomavirus (HPV) vaccination: a call for action in Italy
- Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis
- The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions
- Womens health update: A literature review impacting primary care
- Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis
- Risk of CIN2+ following a diagnosis of genital warts: a nationwide cohort study
- Recurring infection with ecologically distinct human papillomavirus (HPV) types explains high prevalence and diversity
- Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity
- Anal cancer in women: are we appropriately identifying the risks?
- COFAC-Col: A Cervical Cancer Control Networking Initiative in Five French-Speaking African Countries
- Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions
- Veracity and rhetoric in paediatric medicine: a critique of Svoboda and Van Howe's response to the AAP policy on infant male circumcision
- Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
- Authors' reply to Gupta
- HPV vaccination--reaping the rewards of the appliance of science
- Reduction in subsequent HPV related disease was unrelated to vaccination
- Authors' reply to Fiala
- Effect of quadrivalent HPV vaccination on HPV related disease in women treated for cervical or vulvar/vaginal disease